BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21118738)

  • 21. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 22. Bupropion sustained release treatment reduces fatigue in cancer patients.
    Cullum JL; Wojciechowski AE; Pelletier G; Simpson JS
    Can J Psychiatry; 2004 Feb; 49(2):139-44. PubMed ID: 15065748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
    J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bupropion sustained release: a therapeutic overview.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.
    Jim HSL; Hoogland AI; Han HS; Culakova E; Heckler C; Janelsins M; Williams GC; Bower J; Cole S; Desta Z; Babilonia MB; Morrow G; Peppone L
    Contemp Clin Trials; 2020 Apr; 91():105976. PubMed ID: 32147571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
    Rye DB; Dihenia B; Bliwise DL
    Depress Anxiety; 1998; 7(2):92-5. PubMed ID: 9614600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
    J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin.
    Wingerchuk DM; Rodriguez M
    Arch Neurol; 2006 Jul; 63(7):1005-8. PubMed ID: 16831971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bupropion for the treatment of fatigue associated with multiple sclerosis.
    Duffy JD; Campbell J
    Psychosomatics; 1994; 35(2):170-1. PubMed ID: 8171179
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
    Schenck CH; Mahowald MW
    Sleep; 2000 Aug; 23(5):587-8. PubMed ID: 10947025
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful treatment of depression in a Parkinson disease patient with bupropion].
    Leentjens AF; Verhey FR; Vreeling FW
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2157-9. PubMed ID: 11086491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL.
    Modell JG; Rosenthal NE; Harriett AE; Krishen A; Asgharian A; Foster VJ; Metz A; Rockett CB; Wightman DS
    Biol Psychiatry; 2005 Oct; 58(8):658-67. PubMed ID: 16271314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion for depression in schizophrenia.
    Englisch S; Inta D; Eer A; Zink M
    Clin Neuropharmacol; 2010; 33(5):257-9. PubMed ID: 20852411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion therapy for pathological gambling.
    Padala PR; Madaan V; Sattar SP
    Ann Pharmacother; 2007 Mar; 41(3):529. PubMed ID: 17341539
    [No Abstract]   [Full Text] [Related]  

  • 36. Bupropion for amphetamine withdrawal syndrome.
    Chan-Ob T; Kuntawongse N; Boonyanaruthee V
    J Med Assoc Thai; 2001 Dec; 84(12):1763-5. PubMed ID: 11999825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
    Lerman C; Niaura R; Collins BN; Wileyto P; Audrain-McGovern J; Pinto A; Hawk L; Epstein LH
    Psychol Addict Behav; 2004 Dec; 18(4):362-6. PubMed ID: 15631608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bupropion therapy in pregnancy and the occurrence of cardiovascular malformations in infants.
    Thyagarajan V; Robin Clifford C; Wurst KE; Ephross SA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1240-2. PubMed ID: 23109236
    [No Abstract]   [Full Text] [Related]  

  • 39. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
    Mendozzi L; Tronci F; Garegnani M; Pugnetti L
    Mult Scler; 2010 Feb; 16(2):238-47. PubMed ID: 20028705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
    Zellini F; Niepel G; Tench CR; Constantinescu CS
    Mult Scler; 2009 Dec; 15(12):1442-9. PubMed ID: 19995847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.